Transcriptomic Analysis of Allergic Patch Test Reactions in Non-Atopic Patients: A Comparative Study Across Multiple Allergens

Allergic Diseases

Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

Contact Dermatitis

Pesqué D, Planella-Fontanillas N, Borrego L, Sanz-Sánchez T, Zaragoza-Ninet V, Serra-Baldrich E, Miquel-Miquel FJ, Silvestre-Salvador JF, Córdoba-Guijarro S, Sánchez-Gilo A, Mercader-García P, Navarro-Triviño FJ, Ortiz-de-Frutos FJ, Tous-Romero F, Rodríguez-Serna M, Melé-Ninot G, Barrabés-Torrella C, Ruiz-González I, Pastor-Nieto MA, Carrascosa-Carrillo JM, Gómez-de-la-Fuente E, Sánchez-Pedreño-Guillén P, Sánchez-Pérez J, Pereyra-Rodríguez JJ, Gatica-Ortega ME, González-Pérez R, Pujol RM, Descalzo MÁG, García-Doval I, Giménez-Arnau AM

doi: 10.1111/cod.14702

Psoriatic Arthritis

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

RMD Open

Coates LC, Blanco R, Behrens F, Ogdie A, Van den Bosch F, Ranza R, Klionsky Y, Soliman AM, Chen M, Coombs D, Shi L, Urbanik JR, Iyile T, Lippe R, Gossec L

doi: 10.1136/rmdopen-2025-005522

Melanoma and Skin Cancer

Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma

Br J Dermatol

Kamminga NC, Kievits JE, Plaisier PW, Burgers JS, van der Veldt AM, van den Brand JAGJ, Mulder M, Wakkee M, Lugtenberg M, Nijsten T

doi: 10.1093/bjd/ljae377

Psoriatic Arthritis

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis

Arthritis Res Ther

Gladman DD, Nash P, Mease PJ, FitzGerald O, Duench S, Cadatal MJ, Masri KR

doi: 10.1186/s13075-024-03442-2

Atopic Dermatitis

One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis

Adv Ther

Calzavara-Pinton P, Chu CY, Lapeere H, Rossi M, Ferrucci SM, Chung WH, Fougerousse AC, Fomina DS, Holzer G, Čelakovská J, Al-Ahmad M, Tzellos T, Wu J, Ardeleanu M, Bosman K

doi: 10.1007/s12325-024-03049-8

Rheumatoid Arthritis

Machine Learning Analysis of Whole-Blood Transcriptomics Data in Rheumatoid Arthritis Patients Treated with Adalimumab Identifies Predictive Biomarkers of Response

Arthritis Rheumatol

Yap CF, Nair N, Morgan AW, Isaacs JD, Wilson AG, Hyrich K, Barturen G, Riva-Torrubia M, Gut M, Gut I, Alarcón Riquelme ME, Barton A, Plant D

doi: 10.1002/art.43255

Further Publications Dermatology

Comparison of patch testing Brazilian (Green) propolis and Chinese (poplar-type) propolis: Clinical epidemiological study using data from the Information Network of Departments of Dermatology (IVDK)

Contact Dermatitis

Piontek K, Radonjic-Hoesli S, Grabbe J, Drewitz KP, Apfelbacher C, Wöhrl S, Simon D, Lang C, Schubert S

doi: 10.1111/cod.14701

Rheumatoid Arthritis

Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials

Semin Arthritis Rheum

Pugliesi A, Oliveira DGC, Filho VAS, Machado JO, Pereira AG, Bichuette JCS, Sachetto Z, de Carvalho LSF, Bertolo MB

doi: 10.1016/j.semarthrit.2024.152563

Allergic Diseases

Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD)

Contact Dermatitis

Aerts O, Rustemeyer T, Belloni-Fortina A, Badulici S, Dickel H, Garcia Abujeta JL, Giménez-Arnau AM, Gonçalo M, Holden CR, Isaksson M, Latheef F, Ljubojevic Hadzavdic S, Mahler V, Özkaya E, Ponyai G, Pustišek N, Schuttelaar ML, Schwensen J, Spiewak R, Stingeni L, Svedman C, Uter W, White JML, Wilkinson M, Simonsen AB, Duus Johansen J

doi: 10.1111/cod.14824

Related content

Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

Do Large Language Model Chatbots perform better than established patient information resources in answering patient questions? A comparative study on melanoma

Efficacy and safety of tofacitinib in an open-label, long-term extension study in patients with psoriatic arthritis who received adalimumab or tofacitinib in a Phase 3 randomized controlled study: a post hoc analysis

One-Year Insights into the GLOBOSTAD Multinational Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis

Machine Learning Analysis of Whole-Blood Transcriptomics Data in Rheumatoid Arthritis Patients Treated with Adalimumab Identifies Predictive Biomarkers of Response

Comparison of patch testing Brazilian (Green) propolis and Chinese (poplar-type) propolis: Clinical epidemiological study using data from the Information Network of Departments of Dermatology (IVDK)

Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials

Variability in Paediatric Patch Test Practices Across Europe: A Survey From the European Baseline Series (EBS) Working Party on Behalf of the European Society of Contact Dermatitis (ESCD)